Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.23
(-4.17%)
CAD 0.23
(-4.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 532 Thousand CAD | 581.44% |
| 2022 | 78.07 Thousand CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 90.41 Thousand CAD | -87.98% |
| 2024 Q1 | 752.47 Thousand CAD | 71.54% |
| 2024 Q3 | 139.84 Thousand CAD | 54.67% |
| 2023 Q2 | 93.33 Thousand CAD | 0.0% |
| 2023 Q1 | - CAD | -100.0% |
| 2023 Q3 | - CAD | -100.0% |
| 2023 FY | 532 Thousand CAD | 581.44% |
| 2023 Q4 | 438.66 Thousand CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q3 | 70.52 Thousand CAD | 0.0% |
| 2022 FY | 78.07 Thousand CAD | 0.0% |
| 2022 Q4 | 7547.00 CAD | -89.3% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
| Asep Medical Holdings Inc | 21.14 Thousand CAD | -2416.57% |
| BetterLife Pharma Inc. | - CAD | -Infinity% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | - CAD | -Infinity% |
| Rapid Dose Therapeutics Corp. | 1.02 Million CAD | 47.865% |
| Defence Therapeutics Inc. | - CAD | -Infinity% |
| Entheon Biomedical Corp. | 250.32 Thousand CAD | -112.527% |
| Gemina Laboratories Ltd. | - CAD | -Infinity% |
| Glow Lifetech Corp. | 43.93 Thousand CAD | -1110.997% |
| Lexston Life Sciences Corp. | - CAD | -Infinity% |
| Doseology Sciences Inc. | 98.52 Thousand CAD | -439.984% |
| MYND Life Sciences Inc. | - CAD | -Infinity% |
| Nova Mentis Life Science Corp. | 28.34 Thousand CAD | -1776.819% |
| PharmaTher Holdings Ltd. | - CAD | -Infinity% |
| PreveCeutical Medical Inc. | - CAD | -Infinity% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | 10.647% |